dobutamine

Generic: dobutamine

Labeler: hf acquisition co llc, dba healthfirst
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name dobutamine
Generic Name dobutamine
Labeler hf acquisition co llc, dba healthfirst
Dosage Form INJECTION, SOLUTION, CONCENTRATE
Routes
INTRAVENOUS
Active Ingredients

dobutamine hydrochloride 12.5 mg/mL

Manufacturer
HF Acquisition Co LLC, DBA HealthFirst

Identifiers & Regulatory

Product NDC 51662-1337
Product ID 51662-1337_11c1b110-433c-7887-e063-6294a90a1e52
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA074086
Listing Expiration 2026-12-31
Marketing Start 2018-11-26

Pharmacologic Class

Classes
adrenergic beta-agonists [moa] beta-adrenergic agonist [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 516621337
Hyphenated Format 51662-1337

Supplemental Identifiers

RxCUI
1812168
UNII
0WR771DJXV

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name dobutamine (source: ndc)
Generic Name dobutamine (source: ndc)
Application Number ANDA074086 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 12.5 mg/mL
source: ndc
Packaging
  • 20 mL in 1 VIAL, SINGLE-DOSE (51662-1337-1)
  • 10 POUCH in 1 CASE (51662-1337-3) / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1337-2) / 20 mL in 1 VIAL, SINGLE-DOSE
source: ndc

Packages (2)

51662-1337-1 20 mL in 1 VIAL, SINGLE-DOSE (51662-1337-1) 51662-1337-3 10 POUCH in 1 CASE (51662-1337-3) / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1337-2) / 20 mL in 1 VIAL, SINGLE-DOSE

Ingredients (1)

dobutamine hydrochloride (12.5 mg/mL)

Linked Drug Pages (1)

DOBUTAMINE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "11c1b110-433c-7887-e063-6294a90a1e52", "openfda": {"unii": ["0WR771DJXV"], "rxcui": ["1812168"], "spl_set_id": ["7b9ea626-7072-2e77-e053-2a91aa0a9215"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "20 mL in 1 VIAL, SINGLE-DOSE (51662-1337-1)", "package_ndc": "51662-1337-1", "marketing_start_date": "20181126"}, {"sample": false, "description": "10 POUCH in 1 CASE (51662-1337-3)  / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1337-2)  / 20 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "51662-1337-3", "marketing_start_date": "20220612"}], "brand_name": "DOBUTAMINE", "product_id": "51662-1337_11c1b110-433c-7887-e063-6294a90a1e52", "dosage_form": "INJECTION, SOLUTION, CONCENTRATE", "pharm_class": ["Adrenergic beta-Agonists [MoA]", "beta-Adrenergic Agonist [EPC]"], "product_ndc": "51662-1337", "generic_name": "DOBUTAMINE", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "DOBUTAMINE", "active_ingredients": [{"name": "DOBUTAMINE HYDROCHLORIDE", "strength": "12.5 mg/mL"}], "application_number": "ANDA074086", "marketing_category": "ANDA", "marketing_start_date": "20181126", "listing_expiration_date": "20261231"}